S&P 500: 673.80 -1.8% NASDAQ 100: 596.68 -1.9% Dow Jones: 479.22 -2.0%

Joel Greenblatt’s LMAT Holdings & Trades

First Buy
Q1 2018
Duration Held
6 Quarters
Largest Add
Q4 2025
+9,275 Shares
Current Position
16,027 Shares
$1.3 M Value

Joel Greenblatt's LMAT Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 16,027 shares of LeMaitre Vascular, Inc. (LMAT) worth $1.3 M, representing 0.00% of the portfolio. First purchased in 2018-Q1, this short-term holding has been held for 6 quarters.

Based on 13F filings, Joel Greenblatt has maintained this position in LMAT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 9,275 shares. Largest reduction occurred in Q2 2018, reducing 7,053 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's LeMaitre Vascular (LMAT) Holding Value Over Time

Track share changes against reported price movement

Quarterly LeMaitre Vascular (LMAT) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +9,275 Add 137.37% 16,027 $81.10
Q3 2025 +6,752 New Buy 6,752 $87.51
Q1 2022 -5,280 Sold Out 0 $0.00
Q4 2021 +5,280 New Buy 5,280 $50.19
Q2 2018 -7,053 Sold Out 0 $0.00
Q1 2018 +7,053 New Buy 7,053 $36.30

Joel Greenblatt's LeMaitre Vascular Investment FAQs

Joel Greenblatt first purchased LeMaitre Vascular, Inc. (LMAT) in Q1 2018, acquiring 7,053 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held LeMaitre Vascular, Inc. (LMAT) for 6 quarters since Q1 2018.

Joel Greenblatt's largest addition to LeMaitre Vascular, Inc. (LMAT) was in Q4 2025, adding 16,027 shares worth $1.3 M.

According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 16,027 shares of LeMaitre Vascular, Inc. (LMAT), valued at approximately $1.3 M.

As of the Q4 2025 filing, LeMaitre Vascular, Inc. (LMAT) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in LeMaitre Vascular, Inc. (LMAT) was 16,027 shares, as reported at the end of Q4 2025.